^
BIOMARKER:

SMAD4 mutation

i
Other names: HSMAD4, Mothers Against DPP Homolog 4, SMAD, Mothers Against DPP Homolog 4, Deleted In Pancreatic Carcinoma Locus 4, SMAD, Mothers Against DPP Homolog 4, Mothers Against Decapentaplegic, Drosophila, Homolog Of, 4, MADH4, MAD, Mothers Against Decapentaplegic Homolog 4, Mothers Against Decapentaplegic Homolog 4, MAD Homolog 4, SMAD4, SMAD Family Member 4, Deletion Target In Pancreatic Carcinoma 4
Entrez ID:
Related biomarkers:
SMAD4 mutation
CRC
cetuximab + panitumumab
Sensitive: C3 – Early Trials
SMAD4 mutation
CRC
panitumumab
Sensitive: C3 – Early Trials
SMAD4 mutation
CRC
cetuximab
Sensitive: C3 – Early Trials
SMAD4 mutation
Biliary Tract Cancer
toripalimab
Resistant: C3 – Early Trials
SMAD4 mutation
SCCHN
olaparib
Sensitive: D – Preclinical
SMAD4 mutation
Colon Cancer
oxaliplatin
Sensitive: D – Preclinical